Dronedarone in pacemaker patients with paroxysmal atrial fibrillation - DROPPAF

East Sussex NHS Trust0 个研究点开始时间: 2010年7月1日最近更新: 2012年3月19日

适应症

试验速览

暂无简介。

•INCLUSION CRITERIA
•Patients with paroxysmal atrial fibrillation (AF burden 1-50% as defined by DDDRP PPM) during the 3 months prior to induction to the study.
•Patients who have had DDDRP pacemaker implanted for a primary or secondary indication.
•Patients must be on warfarin.
•Patients must be over 18 years old.
•Patients give informed consent form prior to participating in this study.
•Are the trial subjects under 18?
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•Current or previous treatment with amiodarone.
•Patient is suffering with unstable angina in last 1 week.
•Patient has had a myocardial infarction within last 2 months.
•Patient is expecting or has had major cardiac surgery within last 2 months.
•Patient is participating in a conflicting study.
•Patient is mentally incapacitated and cannot consent or comply with follow-up.
•Patient has NYHA class III/ IV heart failure.
•Pregnancy.
•Patient suffers with other cardiac rhythm disorders.
•Recent coronary artery intervention or other factors suggesting clinical instability (ECG, clinical or laboratory findings).
•GFR<30mls/min.

发起方

East Sussex NHS Trust